Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1878-5085
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy ; volume:1 ; number:2 ; day:29 ; month:6 ; year:2010 ; pages:273-292 ; date:6.2010
The EPMA journal / European Association for Predictive, Preventive and Personalised Medicine ; 1, Heft 2 (29.6.2010), 273-292, 6.2010
- Creator
-
Mandel, Silvia A.
- Contributor
-
Morelli, Micaela
Halperin, Ilan
Korczyn, Amos D.
SpringerLink (Online service)
- DOI
-
10.1007/s13167-010-0036-z
- URN
-
urn:nbn:de:1111-2016072635061
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mandel, Silvia A.
- Morelli, Micaela
- Halperin, Ilan
- Korczyn, Amos D.
- SpringerLink (Online service)
Other Objects (12)
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Development of mass spectrometry-based identification and quantification methods for protein biomarkers in Alzheimer’s and Parkinson’s diseases
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Development of mass spectrometry-based identification and quantification methods for protein biomarkers in Alzheimer’s and Parkinson’s diseases
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Development of mass spectrometry-based identification and quantification methods for protein biomarkers in Alzheimer’s and Parkinson’s diseases
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease